Search Results - "Clarkson, James E."

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial by Seider, Michael J., Pugh, Stephanie L., Langer, Corey, Wyatt, Gwen, Demas, William, Rashtian, Afshin, Clausen, Cathy L., Derdel, Jerome David, Cleary, Sean F., Peters, Christopher A., Ramalingam, Ashok, Clarkson, James E., Tomblyn, Michael, Rabinovitch, Rachel A., Kachnic, Lisa A., Berk, Lawrence B.

“…Background Skeletal-related events (SREs), common sequelae of metastatic cancer, are reduced by bisphosphonates. In this study, it was postulated that…”
Get full text

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: Report of RTOG 0517 by Seider, Michael J., Shook, Stephanie, Langer, Corey J., Wyatt, Gwen, Demas, William F., Rashtian, Afshin, Clausen, Cathy L, Derdel, Jerry, Cleary, Sean F, Peters, Christopher A., Ramalingam, Ashok, Clarkson, James E., Tomblyn, Michael B., Rabinovitch, Rachel, Kachnic, Lisa A., Berk, Lawrence B.

“…Abstract only TPS9150 Background: Skeletal related events (SREs) diminish quality of life (QOL) as well as overall survival (OS) in patients with bone…”
Get full text